New European legislation impacts on both cancer trials and drug approval
2nd Nov 2005, 15:35 GMT
New European legislation looks set to expedite patient access to important oncology products, according to discussions at the 13th European Cancer Conference (ECCO). Yet concerns were also voiced that the recently implemented Clinical Trials Directive is having a converse effect, restricting the number of new cancer trials carried out by impinging on the conduct of international, investigator-initiated, multicentre studies within Europe.
New European legislation impacts on both cancer trials and drug approval related news:
- Drug Approval Trials Lengthen — Red Herring
- Oxford BioMedica seeks £30m for cancer drug trials — Business
- Antisoma Presents AS1404 Data at ECCO -- the European Cancer Conference — ArriveNet : Press Releases
- Expanded use sought for colon cancer drug — News-Medical News Feed
- pSivida Announces BrachySil Phase IIb Clinical Trials for Liver Cancer Commence Following Approval by HSA — NSTI nanoPRwire
- FDA Approves New Cancer Drug — ConsumerAffairs.Com News for Seniors
- Dendreon trials boost case for cancer drug — The Seattle Times
- pSivida initiates Asian trial of liver cancer drug — Pharmaceutical Business Review Online
- BSD Medical's Cancer Therapy Makes Hot News — Radiology News from StratCenter.com
- Research unveils new, reliable approach to drug delivery for cancer patients — EurekAlert! - Cancer
Latest news from EurekAlert! - Biology:
- Climate change creates dramatic decline in red-winged black bird population
- Developing uses for sugar-cane bagasse: Biotechnology applied to the paper industry
- University of Iowa scientists explore function of 'junk DNA'
- Tailored treatments: Promising designer drug provides new insight into cancer biology
- Scientists urge collaborative action to address effects of global environmental change
- New insight about the source of anxiety in Rett syndrome
- Sticky proteins provide new insight into drug action
- New study finds on/off switch for septic shock
- Transforming knowledge into economic benefits -- EPSRC's First Knowledge Transfer Challenge Awards
- Wielding the subtle weapons of a fungus